Public social platforms
Track the public conversation your Live Searches define across X, Instagram, TikTok, Facebook, LinkedIn, Snapchat, and Reddit.
Public intelligence for pharmaceutical teams
A therapy can be understood clinically and still be misunderstood publicly.
Patients discuss access and experience. Advocates challenge evidence. Trial news moves through media and markets. Socialhose gives communications, insights, and medical-affairs teams a live view of monitored public conversation, with the source context needed to route what warrants review.
Trusted by
Pharmaceutical listening facts
Language filters
Separate supported multilingual conversation for review by teams with the relevant language and market context.
Mentions retain context
Move from a trend back to the captured content, author, time, engagement, media, and enrichment behind it.
The conversation around the medicine
Public narrative does not respect the org chart.
Follow the connected questions that move between patients, advocates, clinicians, media, investors, and the wider public without pretending one signal answers every regulated function.
What are patients and caregivers saying about access and experience?
Track public language around affordability, availability, dosing experience, adherence barriers, support programs, and care navigation. Treat each post as a signal for authorized review, not as validated medical evidence.
How is the therapy narrative changing?
Compare the intended message with the themes, entities, claims, sentiment, and emotion that gain traction in monitored conversation. See where understanding fragments by platform, language, or market.
Which trial or evidence discussion warrants review?
Follow study names, molecules, indications, endpoints, conferences, investigators, and known issue terms. Alerts can surface a monitored shift; medical, legal, safety, and communications teams decide its significance and response.
Where are access, trust, and market narratives converging?
Connect public discussion of price, supply, policy, evidence, competitors, and corporate reputation. Keep the source material visible when the same issue reaches different stakeholders with different stakes.
From signal to cross-functional context
A watch floor built for human review
Socialhose structures and distributes public-conversation evidence. It does not replace pharmacovigilance, medical review, or regulated case-processing systems.
Therapy and entity context
Extract brands, products, people, organizations, locations, topics, and key points from each captured Mention.
Sentiment, emotion, and intent
Use structured enrichment to distinguish questions, complaints, praise, information, and promotion while retaining the source text for review.
Relevance and noise controls
Reduce spam, duplicates, and keyword coincidence before routing a monitored signal to a specialist team.
Alerts and executive summaries
Distribute source-linked alerts, digests, themes, sentiment context, and recommended review actions at the cadence the workflow requires.
Cross-functional distribution
Use mailing lists and stakeholder digests to give communications, insights, medical, safety, and leadership the appropriate view of the same public evidence.
Exports, webhooks, and API
Export CSV, JSON, Excel, or PDF, or use plan-gated webhooks and scoped API access to connect approved downstream workflows.
We publish what the platform can reveal
A public-health conversation can be measured without flattening the people inside it
The Texas Healthcare Conversation Report (Edition 02) analyzed 13 weeks of public posts and measured the Voice Gap between institutional healthcare messaging and patient experience. It is proof of method, not a fabricated pharma customer story.
A dated corpus covering Texas healthcare conversation from April through June 2026.
Institutional posts ran 78% positive while patient posts ran 53% negative.
A distinct access conversation centered on appointments, vaccines, and care navigation.
Published by Social Knowing, our independent research journal. Report figures derive from the Socialhose Public API and are frozen at publication; the live monitor carries the current reading.
Questions pharmaceutical teams ask first
Questions pharmaceutical teams ask first
Does Socialhose replace pharmacovigilance or case processing?
No. Socialhose can surface and enrich monitored public Mentions for review. Your authorized safety and medical teams remain responsible for validation, reportability decisions, follow-up, timelines, privacy, and every regulated workflow.
Which public platforms can we monitor?
Live collection supports X, Instagram, TikTok, Facebook, LinkedIn, and Reddit. Available public content and query syntax vary by platform and the Live Search you configure.
Does the platform monitor private patient communities?
No. Socialhose monitors public social conversation. It does not access private groups, direct messages, patient records, or closed communities.
Can the AI determine whether a claim or event is medically valid?
No. AI enrichment can organize sentiment, emotion, intent, entities, products, topics, and relevance. Qualified people must review the source and decide medical validity, significance, and response.
How much historical context is available?
Historical availability and lookback vary by platform and Live Search type. Socialhose leads with live collection and provides historical context where the selected source supports it.
Can different functions work from the same evidence?
Yes. Campaigns, alerts, digests, statuses, exports, mailing lists, and plan-gated API access can support separate review and distribution paths. Each team keeps responsibility for its own authorized process.
Is there an annual contract?
No. Socialhose plans are month-to-month with published pricing, no setup fee, and no minimum term.
Put public context beside the decision
Bring the public conversation into the room before the next decision.
Give communications, medical affairs, patient engagement, and investor relations a shared view of the public signals shaping a medicine's narrative.